Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has appointed Jerry White as a company advisor. A passionate activist, author and social entrepreneur, White is the recipient of numerous human rights and leadership awards, including sharing the Nobel Peace Prize in 1997. In his new role, White will advise MINDCURE on its mission to revolutionize mental health treatments worldwide through the development and scaling of science-backed psychedelic medicine. White shares in the 1997 Nobel Prize for Peace, which was awarded to the International Campaign to Ban Landmines, an organization that he leads. White is a senior Ashoka Fellow and has worked alongside the late Diana, Princess of Wales, and Her Majesty Queen Noor of Jordan. He was also appointed U.S. Deputy Assistant Secretary of State by President Barack Obama. When he was 20, he lost a leg to a landmine while hiking in northern Israel and consequently co-founded Survivor Corps, an organization created by and for survivors to help victims of war rebuild their lives. He is currently a professor of practice at the University of Virginia, where he teaches on religion, violence and strategy. White noted that his own experience learning to build resilience for trauma recovery, as well as engaging large audiences to power global movements, would help MINDCURE and the psychedelics industry advance revolutionary wellness worldwide. “Never shying away from audacious goals, driving transformational global movements, asking the toughest of questions, and translating them to strategy — this is what Jerry brings and why I am so thrilled to welcome him to the advisory board at MINDCURE,” said MINDCURE president and CEO Kelsey Ramsden in the press release. “It’s an honor to welcome a truly noble and humane impact strategist to our advisory board. I look forward to working with Jerry on our visionary strategy to build mental wealth worldwide.”
To view the full press release, visit https://ibn.fm/Ed4Fs
About Mind Cure Health Inc.
MINDCURE is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. The company is developing digital therapeutics technology and researching psychedelic compounds to support access to safe, evidence-based, psychedelic-assisted therapies globally. For more information about the company, please visit www.MindCure.com.
NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php